Skip Navigation

FDA Approves CAR T-Cell Therapy for Non-Hodgkin Lymphoma

CAR T-cell diagram
October 18, 2017
Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration (FDA) today. Dana-Farber/Brigham and Women's Cancer Center,...
Read Story
  • Explore the Newsroom

    News Releases

    News releases about cancer care, cancer research, and cancer treatment by Dana-Farber Cancer Institute doctors and researchers.

    News Coverage

    Get the latest news about Dana-Farber Cancer Institute. 

    Publications

    Read the latest issues of Dana-Farber publications.

    Dana-Farber Spotlight

    Sign up to receive Dana-Farber Spotlight, our email newsletter.
    View the current issue
    Subscribe now
    Unsubscribe from mailings

    Insight Blog

    Insight features the latest in cancer care and research news from Dana-Farber.

    For Journalists

    Dana-Farber welcomes the opportunity to partner with journalists. Find contacts, resources, and more. 
  • View Our Events Calendar

    View Dana-Farber's calendar of events, including nutrition seminars, health and wellness classes, patient education, community outreach and fundraising events, and support groups.

    caregiver support group


    Participants in a caregiver support group